If diagnosed, you may be at an early stage or late stage of liver disease. Here is how our products helps you to examine the disease
LIVERFASt™ can safely provide the complete liver assessment clinically needed, whether a COVID-19 patient has pre-existing conditions such as hepatitis B or C, NASH or Fatty Liver or even those with undiagnosed liver disease.
© Copyright Fibronostics. All Rights Reserved
Fibronostics is a healthcare technology company focused on transforming non-invasive solutions for early disease intervention.